Postmarketing Colitis Cases Associated With Alpelisib Use Reported to the US Food and Drug Administration

被引：3
|
作者：
Sullivan, Kathleen M. [1 ]
Dores, Graca M. [1 ]
Nayernama, Afrouz [1 ]
Prowell, Tatiana M. [2 ,3 ]
Pradhan, Shan M. [2 ]
Osgood, Christy [2 ]
Jones, S. Christopher [1 ]
机构：
[1] US FDA, Div Pharmacovigilance, Off Surveillance & Epidemiol, Ctr Drug Evaluat, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
[2] US FDA, Off Oncol Dis, Ctr Drug Evaluat, Silver Spring, MD USA
[3] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
来源：
JAMA ONCOLOGY | 2022年 / 8卷 / 10期
关键词：
D O I：
10.1001/jamaoncol.2022.3249
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1503 / 1505
页数：4
相关论文
共 50 条
  • [21] Hysteroscopic Sterilization With Essure: Summary of the US Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance
    Steward, Rachel
    OBSTETRICS AND GYNECOLOGY, 2017, 129 (04): : 752 - 753
  • [22] Twenty Years of Targeted and Biologic Immunomodulatory Drugs: Postmarketing Modifications of Drug Labels Approved by the US Food and Drug Administration
    Berman, Julia
    Yavne, Yarden
    Edel, Yonatan
    Elkayam, Ori
    Furer, Victoria
    Shepshelovich, Daniel
    MAYO CLINIC PROCEEDINGS, 2022, 97 (08) : 1512 - 1522
  • [23] US food and drug administration
    Goodman, Jesse
    ONCOLOGY-NEW YORK, 2006, 20 (08): : 946 - 946
  • [24] US Food and Drug Administration
    Blumenthal, G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S37 - S37
  • [25] US Food and Drug Administration analysis of strokes associated with raloxifene
    Wyeth, Jo
    Green, Lanh
    Avigan, Mark
    OBSTETRICS AND GYNECOLOGY, 2007, 109 (04): : 999 - 999
  • [26] Use of radioanalytical techniques at the US Food and Drug Administration.
    Anderson, DL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U93 - U93
  • [27] Paliperidone-Associated Hyponatremia Report of a Fatal Case With Analysis of Cases Reported in the Literature and to the US Food and Drug Administration Adverse Event Reporting System
    Mazhar, Faizan
    Carnovale, Carla
    Haider, Nafis
    Ahmed, Rafeeque
    Taha, Murtada
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2020, 40 (02) : 202 - 205
  • [28] Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986–2019
    Shaokui Wei
    Manette T. Niu
    Graça M. Dores
    Drugs - Real World Outcomes, 2021, 8 : 253 - 262
  • [29] The Food and Drug Administration's use of postmarketing (phase IV) study requirements: Exception to the rule?
    Steenburg, Charles
    FOOD AND DRUG LAW JOURNAL, 2006, 61 (02) : 295 - 384
  • [30] Patient-Reported Outcomes in Orphan Drug Labels Approved by the US Food and Drug Administration
    Hong, Yoon Duk
    Villalonga-Olives, Ester
    Perfetto, Eleanor M.
    VALUE IN HEALTH, 2019, 22 (08) : 925 - 930
12345